denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Thursday, December 3, 2015
3:00 PM-7:00 PM
Friday, December 4, 2015
7:00 AM-6:00 PM
12:00 PM-5:00 PM
12:30 PM-5:00 PM
Training Program Directors Workshop
1:00 PM-6:00 PM
2:00 PM-5:00 PM
American Board of Internal Medicine Maintenance of Certification Learning Session
Special-Interest Sessions
5:00 PM-7:00 PM
Saturday, December 5, 2015
7:00 AM-6:00 PM
7:30 AM-9:00 AM
Disorders of Platelet Number or Function
311. Disorders of Platelet Number or Function: Immune Thrombocytopenia and Platelet Survival
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
653. Myeloma: Therapy, excluding Transplantation: Advances in Newly Diagnosed and Relapsed Myeloma
Oral and Poster Abstracts
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
701. Experimental Transplantation: Basic Biology, Engraftment, and Disease Activity
Oral and Poster Abstracts
Health Services and Outcomes Research Non-Malignant Conditions
9:00 AM-9:30 AM
9:00 AM-7:30 PM
9:30 AM-11:00 AM
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
Myeloproliferative Syndromes: Clinical
634. Myeloproliferative Syndromes: Clinical: Early and Late Stage Trials in MPN
Oral and Poster Abstracts
Clinical Allogeneic Transplantation: Results
Special Education Session on Clinical Applications of Newly Approved Drugs
Special-Interest Sessions
11:00 AM-12:30 PM
11:00 AM-5:00 PM
11:15 AM-12:15 PM
Continuing Conversations with the Speakers on Checkpoint Please?
Continuing Conversations with the Speakers
Continuing Conversations with the Speakers on Genomics, the Next Frontier: Novel Approaches to Study Cancer and Development
Continuing Conversations with the Speakers
Patients with Acute Myeloid Leukemia Unfit for Intensive Therapy
How I Treat: Bringing Science to Clinical Dilemmas
11:30 AM-12:30 PM
12:00 PM-1:30 PM
Hemoglobinopathies, Excluding Thalassemia Clinical
Disorders of Platelet Number or Function
311. Disorders of Platelet Number or Function: Genetics of Inherited and Acquired Thrombocytopenias
Oral and Poster Abstracts
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Myelodysplastic Syndromes Clinical Studies
637. Myelodysplastic Syndromes Clinical Studies: New Therapeutic Approaches
Oral and Poster Abstracts
Adoptive Immunotherapy
12:30 PM-1:30 PM
1:30 PM-2:00 PM
2:00 PM-3:30 PM
Disorders of Platelet Number or Function
311. Disorders of Platelet Number or Function: Thrombotic Microangiopathies
Oral and Poster Abstracts
Non-Hodgkin Lymphoma: Biology, excluding Therapy
622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Refining The Molecular Roadmap In NHL
Oral and Poster Abstracts
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
3:30 PM-4:00 PM
4:00 PM-5:30 PM
Blood Coagulation and Fibrinolytic Factors
321. Blood Coagulation and Fibrinolytic Factors: Biochemistry and Engineering of Coagulation Proteins
Oral and Poster Abstracts
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Chronic Myeloid Leukemia: Therapy
632. Chronic Myeloid Leukemia: Therapy: Clinical Trials, Observations, and Molecular Monitoring
Oral and Poster Abstracts
Myelodysplastic Syndromes Basic and Translational Studies
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
Clinical Allogeneic Transplantation: Results
5:30 PM-7:30 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Regulation of Iron Metabolism
Thalassemia and Globin Gene Regulation
Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science
113. Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science: Poster I
Oral and Poster Abstracts
Hemoglobinopathies, Excluding Thalassemia Clinical
Granulocytes, Monocytes and Macrophages
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Platelet Activation and Biochemistry
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster I
Oral and Poster Abstracts
Disorders of Platelet Number or Function
Blood Coagulation and Fibrinolytic Factors
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Antithrombotic Therapy
Basic Science and Clinical Practice in Blood Transfusion
Hematopoietic Stem and Progenitor Biology
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster I
Oral and Poster Abstracts
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster I
Oral and Poster Abstracts
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster I
Oral and Poster Abstracts
Bone Marrow Failure
Chromosomal Rearrangements and DNA Repair
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I
Oral and Poster Abstracts
Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases
605. Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases: Poster I
Oral and Poster Abstracts
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Clinical Studies
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I
Oral and Poster Abstracts
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster I
Oral and Poster Abstracts
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I
Oral and Poster Abstracts
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster I
Oral and Poster Abstracts
Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes Basic and Translational Studies
636. Myelodysplastic Syndromes Basic and Translational Studies: Poster I
Oral and Poster Abstracts
Myelodysplastic Syndromes Clinical Studies
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I
Oral and Poster Abstracts
Myeloma: Therapy, excluding Transplantation
Malignant Stem and Progenitor Cells
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster I
Oral and Poster Abstracts
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster I
Oral and Poster Abstracts
Adoptive Immunotherapy
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I
Oral and Poster Abstracts
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Clinical Autologous Transplantation: Results
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research Non-Malignant Conditions
901. Health Services and Outcomes Research Non-Malignant Conditions: Poster I
Oral and Poster Abstracts
Health Services and Outcomes Research Malignant Diseases
6:30 PM-9:00 PM
Sunday, December 6, 2015
7:00 AM-9:00 AM
7:00 AM-5:00 PM
7:30 AM-9:00 AM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Chromosomal Rearrangements and DNA Repair
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
621. Hodgkin Lymphoma: Biology, excluding Therapy: Biological Insights and Clinical Impact
Oral and Poster Abstracts
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Myeloma: Therapy, excluding Transplantation
653. Myeloma: Therapy, excluding Transplantation: Amyloidosis and Related Plasma Cell Disorders
Oral and Poster Abstracts
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
801. Gene Therapy and Transfer: Gene Therapy for Hemoglobinopathies and Inherited Bleeding Disorders
Oral and Poster Abstracts
9:00 AM-9:30 AM
9:00 AM-8:00 PM
9:30 AM-11:00 AM
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Blood Coagulation and Fibrinolytic Factors
321. Blood Coagulation and Fibrinolytic Factors: Coagulation Proteins and Blood Vessels
Oral and Poster Abstracts
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
9:30 AM-11:15 AM
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
10:00 AM-5:00 PM
11:00 AM-12:30 PM
11:15 AM-12:15 PM
Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia
How I Treat: Bringing Science to Clinical Dilemmas
Continuing Conversations with the Speakers on Harnessing T cells in Therapy of Hematologic Malignancy
Continuing Conversations with the Speakers
Continuing Conversations with the Speakers on Send in the Clones: Stem Cell Succession, Replicative Stress and Somatic Reversion
Continuing Conversations with the Speakers
Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia
How I Treat: Bringing Science to Clinical Dilemmas
Optimizing Diagnostic Approaches for von Willebrand Disease
How I Treat: Bringing Science to Clinical Dilemmas
Patients with Chronic Myeloid Leukemia Who Want to Become Pregnant
How I Treat: Bringing Science to Clinical Dilemmas
Trainee Simultaneous Didactic Session
Trainee Simultaneous Didactic Session
11:15 AM-12:30 PM
11:30 AM-12:30 PM
12:00 PM-1:30 PM
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
Oral and Poster Abstracts
Hematopoietic Stem and Progenitor Biology
Acute Lymphoblastic Leukemia: Clinical Studies
612. Acute Lymphoblastic Leukemia: Clinical Studies: Special Aspects of Childhood ALL
Oral and Poster Abstracts
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: NHL New Drugs
Oral and Poster Abstracts
Gene Therapy and Transfer
801. Gene Therapy and Transfer: Gene Therapy for Immune Disorders and Cancer
Oral and Poster Abstracts
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Quality of Life and Health Outcomes
Oral and Poster Abstracts
12:30 PM-1:30 PM
1:30 PM-2:00 PM
2:00 PM-4:00 PM
Plenary
4:00 PM-4:30 PM
4:30 PM-5:45 PM
4:30 PM-6:00 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Disorders of Coagulation or Fibrinolysis
Bone Marrow Failure
508. Bone Marrow Failure: Attack on the Clones Hematopoietic Stem/Progenitor Cell Defects
Oral and Poster Abstracts
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation I
Oral and Poster Abstracts
Oncogenes and Tumor Suppressors
603. Oncogenes and Tumor Suppressors: Epigenetic Transformation in Myeloid and Lymphoid Malignancies
Oral and Poster Abstracts
Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases
Acute Myeloid Leukemia: Clinical Studies
613. Acute Myeloid Leukemia: Clinical Studies: Advances in Targeted Therapy
Oral and Poster Abstracts
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs
Oral and Poster Abstracts
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Aggressive NHL MCL, Burkitt, T-cell
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Therapy
632. Chronic Myeloid Leukemia: Therapy: Treatment-Free Remission, Mutations, and Prognosis
Oral and Poster Abstracts
Myeloproliferative Syndromes: Clinical
634. Myeloproliferative Syndromes: Clinical: Molecular Genetics and Prognosis of MPN
Oral and Poster Abstracts
Myelodysplastic Syndromes Basic and Translational Studies
636. Myelodysplastic Syndromes Basic and Translational Studies: Emerging Paradigms in MDS Pathobiology
Oral and Poster Abstracts
CLL: Biology and Pathophysiology, excluding Therapy
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
653. Myeloma: Therapy, excluding Transplantation: Novel Drugs and Combinations
Oral and Poster Abstracts
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Autologous Transplantation: Results
Clinical Allogeneic Transplantation: Results
6:00 PM-8:00 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Regulation of Iron Metabolism
Thalassemia and Globin Gene Regulation
Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science
113. Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science: Poster II
Oral and Poster Abstracts
Hemoglobinopathies, Excluding Thalassemia Clinical
Granulocytes, Monocytes and Macrophages
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Platelet Activation and Biochemistry
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster II
Oral and Poster Abstracts
Disorders of Platelet Number or Function
Blood Coagulation and Fibrinolytic Factors
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Antithrombotic Therapy
Basic Science and Clinical Practice in Blood Transfusion
Hematopoietic Stem and Progenitor Biology
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster II
Oral and Poster Abstracts
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster II
Oral and Poster Abstracts
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster II
Oral and Poster Abstracts
Bone Marrow Failure
Chromosomal Rearrangements and DNA Repair
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II
Oral and Poster Abstracts
Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases
605. Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases: Poster II
Oral and Poster Abstracts
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Clinical Studies
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II
Oral and Poster Abstracts
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster II
Oral and Poster Abstracts
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II
Oral and Poster Abstracts
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II
Oral and Poster Abstracts
Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes Basic and Translational Studies
636. Myelodysplastic Syndromes Basic and Translational Studies: Poster II
Oral and Poster Abstracts
Myelodysplastic Syndromes Clinical Studies
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy
652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II
Oral and Poster Abstracts
Myeloma: Therapy, excluding Transplantation
Malignant Stem and Progenitor Cells
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster II
Oral and Poster Abstracts
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster II
Oral and Poster Abstracts
Adoptive Immunotherapy
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II
Oral and Poster Abstracts
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Clinical Autologous Transplantation: Results
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research Non-Malignant Conditions
901. Health Services and Outcomes Research Non-Malignant Conditions: Poster II
Oral and Poster Abstracts
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Poster II
Oral and Poster Abstracts
7:00 PM-8:00 PM
Monday, December 7, 2015
7:00 AM-8:30 AM
Regulation of Iron Metabolism
Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science
Platelet Activation and Biochemistry
301. Platelet Activation and Biochemistry: Platelet Production and Function
Oral and Poster Abstracts
Blood Coagulation and Fibrinolytic Factors
321. Blood Coagulation and Fibrinolytic Factors: Coagulation Proteins in Development and Disease
Oral and Poster Abstracts
Antithrombotic Therapy
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation II
Oral and Poster Abstracts
Oncogenes and Tumor Suppressors
603. Oncogenes and Tumor Suppressors: Post-Transcriptional and Metabolic Mechanisms of Leukemogenesis
Oral and Poster Abstracts
Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases
Acute Myeloid Leukemia: Clinical Studies
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Epigenetic Approaches
Oral and Poster Abstracts
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Basic Science
CLL: Biology and Pathophysiology, excluding Therapy
641. CLL: Biology and Pathophysiology, excluding Therapy: Signaling and Targeted Drug Therapies for CLL
Oral and Poster Abstracts
CLL: Therapy, excluding Transplantation:
642. CLL: Therapy, excluding Transplantation: Upfront CLL Therapy Excluding Transplantation
Oral and Poster Abstracts
Myeloma: Biology and Pathophysiology, excluding Therapy
651. Myeloma: Biology and Pathophysiology, excluding Therapy: Sensitivity and Resistance Mechanisms
Oral and Poster Abstracts
Myeloma: Therapy, excluding Transplantation
653. Myeloma: Therapy, excluding Transplantation: Novel Combinations in Immuno-Oncology
Oral and Poster Abstracts
Cell Collection and Processing
Clinical Autologous Transplantation: Results
Health Services and Outcomes Research Non-Malignant Conditions
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Outcomes in Acute Myeloid Leukemia
Oral and Poster Abstracts
7:00 AM-11:30 AM
7:00 AM-5:00 PM
9:00 AM-10:00 AM
10:00 AM-10:30 AM
10:00 AM-2:00 PM
10:00 AM-8:00 PM
10:30 AM-12:00 PM
Regulation of Iron Metabolism
102. Regulation of Iron Metabolism: Iron Metabolism Clinical and Translational
Oral and Poster Abstracts
Hemoglobinopathies, Excluding Thalassemia Clinical
114. Hemoglobinopathies, Excluding Thalassemia Clinical: Promising Therapies in Sickle Cell Disease
Oral and Poster Abstracts
Disorders of Coagulation or Fibrinolysis
322. Disorders of Coagulation or Fibrinolysis: Novel Treatment Strategies in Hemophilia
Oral and Poster Abstracts
Oncogenes and Tumor Suppressors
Acute Myeloid Leukemia: Clinical Studies
613. Acute Myeloid Leukemia: Clinical Studies: Improvements in Risk-Stratification
Oral and Poster Abstracts
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeting Approaches
Oral and Poster Abstracts
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents
625. Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents: Novel Therapies and Targets in Lymphoma
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Therapy
632. Chronic Myeloid Leukemia: Therapy: Clinical and Molecular Predictors of Outcomes and Toxicities
Oral and Poster Abstracts
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes Clinical Studies
637. Myelodysplastic Syndromes Clinical Studies: Prognostic Systems and Molecular Testing
Oral and Poster Abstracts
CLL: Biology and Pathophysiology, excluding Therapy
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Health Services and Outcomes Research Non-Malignant Conditions
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Clinical Trials and Health Outcomes
Oral and Poster Abstracts
12:00 PM-1:30 PM
12:15 PM-1:15 PM
Trainee Simultaneous Didactic Session
Trainee Simultaneous Didactic Session
1:30 PM-2:30 PM
2:30 PM-2:45 PM
2:45 PM-4:15 PM
Thalassemia and Globin Gene Regulation
112. Thalassemia and Globin Gene Regulation: Understanding and Manipulating Globin Gene Regulation
Oral and Poster Abstracts
Granulocytes, Monocytes and Macrophages
Pathophysiology of Thrombosis
Basic Science and Clinical Practice in Blood Transfusion
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Bone Marrow Failure
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Advances in Immunotherapy
Oral and Poster Abstracts
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Non-Hodgkin Lymphoma: Biology, excluding Therapy
622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: New Targets In Aggressive Lymphoma
Oral and Poster Abstracts
Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents
Myelodysplastic Syndromes Basic and Translational Studies
CLL: Therapy, excluding Transplantation:
642. CLL: Therapy, excluding Transplantation: Management of CLL Therapy Excluding Transplantation
Oral and Poster Abstracts
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Health Services and Outcomes Research Non-Malignant Conditions
4:30 PM-6:00 PM
Thalassemia and Globin Gene Regulation
112. Thalassemia and Globin Gene Regulation: Therapeutic Approaches to Thalassemia and Their Mechanisms
Oral and Poster Abstracts
Disorders of Coagulation or Fibrinolysis
322. Disorders of Coagulation or Fibrinolysis: Clinical Aspects of Bleeding Disorders
Oral and Poster Abstracts
Pathophysiology of Thrombosis
331. Pathophysiology of Thrombosis: Procoagulant States Assessment and Risks
Oral and Poster Abstracts
Basic Science and Clinical Practice in Blood Transfusion
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: DLBCL Beyond R-CHOP
Oral and Poster Abstracts
Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents
Myeloproliferative Syndromes: Clinical
CLL: Therapy, excluding Transplantation:
642. CLL: Therapy, excluding Transplantation: Relapsed/Refractory CLL Therapy Excluding Transplantation
Oral and Poster Abstracts
Myeloma: Biology and Pathophysiology, excluding Therapy
651. Myeloma: Biology and Pathophysiology, excluding Therapy: Exploring the Biology of Multiple Myeloma
Oral and Poster Abstracts
Malignant Stem and Progenitor Cells
661. Malignant Stem and Progenitor Cells: Novel Mechanisms of Leukemia Stem Cell Function
Oral and Poster Abstracts
Adoptive Immunotherapy
Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Clinical Trials
Oral and Poster Abstracts
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Economic Burdens of Therapy
Oral and Poster Abstracts
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Toxicities of Therapy
Oral and Poster Abstracts
4:30 PM-6:30 PM
6:00 PM-8:00 PM
Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron
Regulation of Iron Metabolism
Thalassemia and Globin Gene Regulation
Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science
113. Hemoglobinopathies, Excluding Thalassemia Basic and Translational Science: Poster III
Oral and Poster Abstracts
Hemoglobinopathies, Excluding Thalassemia Clinical
Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections
Platelet Activation and Biochemistry
Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion
302. Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion: Poster III
Oral and Poster Abstracts
Disorders of Platelet Number or Function
Blood Coagulation and Fibrinolytic Factors
Disorders of Coagulation or Fibrinolysis
Pathophysiology of Thrombosis
Basic Science and Clinical Practice in Blood Transfusion
Hematopoiesis: Epigenetic, Transcriptional and Translational Control
503. Hematopoiesis: Epigenetic, Transcriptional and Translational Control: Poster III
Oral and Poster Abstracts
Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation
504. Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation: Poster III
Oral and Poster Abstracts
Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells
506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster III
Oral and Poster Abstracts
Bone Marrow Failure
Chromosomal Rearrangements and DNA Repair
Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation
Oncogenes and Tumor Suppressors
Molecular Pharmacology and Drug Resistance in Myeloid Diseases
604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III
Oral and Poster Abstracts
Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases
605. Molecular Pharmacology, Drug Resistance Lymphoid and Other Diseases: Poster III
Oral and Poster Abstracts
Acute Lymphoblastic Leukemia: Clinical Studies
Acute Myeloid Leukemia: Clinical Studies
Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III
Oral and Poster Abstracts
Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation
615. Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation: Poster III
Oral and Poster Abstracts
Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation
616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III
Oral and Poster Abstracts
Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis
Hodgkin Lymphoma: Biology, excluding Therapy
Non-Hodgkin Lymphoma: Biology, excluding Therapy
Lymphoma: Chemotherapy, excluding Pre-Clinical Models
Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models
624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster III
Oral and Poster Abstracts
Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents
625. Lymphoma: Pre-Clinical Chemotherapy and Biologic Agents: Poster III
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy
631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III
Oral and Poster Abstracts
Chronic Myeloid Leukemia: Therapy
Myeloproliferative Syndromes: Clinical
Myeloproliferative Syndromes: Basic Science
Myelodysplastic Syndromes Basic and Translational Studies
636. Myelodysplastic Syndromes Basic and Translational Studies: Poster III
Oral and Poster Abstracts
CLL: Biology and Pathophysiology, excluding Therapy
CLL: Therapy, excluding Transplantation:
Myeloma: Biology and Pathophysiology, excluding Therapy
Myeloma: Therapy, excluding Transplantation
Malignant Stem and Progenitor Cells
Experimental Transplantation: Basic Biology, Engraftment and Disease Activity
701. Experimental Transplantation: Basic Biology, Engraftment and Disease Activity: Poster III
Oral and Poster Abstracts
Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects
702. Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects: Poster III
Oral and Poster Abstracts
Adoptive Immunotherapy
Cell Collection and Processing
Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities
Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence
Clinical Allogeneic Transplantation: Results
Gene Therapy and Transfer
Chemical Biology and Experimental Therapeutics
Health Services and Outcomes Research Non-Malignant Conditions
901. Health Services and Outcomes Research Non-Malignant Conditions: Poster III
Oral and Poster Abstracts
Health Services and Outcomes Research Malignant Diseases
902. Health Services and Outcomes Research Malignant Diseases: Poster III
Oral and Poster Abstracts
6:15 PM-7:45 PM
Granulocytes, Monocytes and Macrophages
Antithrombotic Therapy
Hematopoietic Stem and Progenitor Biology
501. Hematopoietic Stem and Progenitor Biology: Extrinsic and Intrinsic Regulators of Self-Renewal
Oral and Poster Abstracts